Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Candida EVs, Nrg1, and Hyphal Suppression
2026-09-21
This study identifies a concentration- and time-dependent feedback mechanism in which Candida albicans extracellular vesicles increase NRG1 expression and suppress hyphal development through an SKO1-associated regulatory axis. Genetic, transcriptomic, and mouse candidemia experiments indicate that EV cargo proteins can reduce fungal virulence, although the physiological relevance and molecular identity of the active cargo remain to be established.
-
Beyond Hits: Translating Immune Phenotypes
2026-09-21
A mechanism-first framework for using multiparametric PBMC phenotyping and curated small-molecule collections to connect immune-cell responses with actionable inflammation biology.
-
Proteinase K: Assay Design Beyond DNA Prep
2026-09-20
Proteinase K is more than a genomic DNA isolation enzyme: it is a useful proteolysis control for interpreting inhibitor assays. This article connects its biochemical selectivity and operating range with the SARS-CoV-2 3CLpro screening strategy reported for merbromin.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-09-19
Learn how SKU K1062 supports reproducible fluorescent RNA probe synthesis for in situ hybridization and Northern blot workflows linked to cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers probe design, Cy5-UTP optimization, interpretation, and practical product selection.
-
ZNF263–ULK1 Autophagy Axis in Cholangiocarcinoma
2026-09-18
The reference study identifies ZNF263 as an oncogenic transcription factor in intrahepatic cholangiocarcinoma and connects its activity to ULK1-dependent autophagy. By integrating tissue analysis, functional assays, CUT&Tag, transcriptomics, enhancer validation, and rescue experiments, the authors propose a mechanistic route linking chromatin regulation with tumor-cell proliferation.
-
Pioglitazone Workflows for PPARγ Research
2026-09-18
Pioglitazone is a practical PPARγ agonist for connecting metabolic transcriptional control with beta-cell resilience and inflammatory process modulation. This workflow-oriented guide translates macrophage-polarization evidence into cell, barrier, and disease-model assays while emphasizing formulation, controls, and interpretation.
-
Streptavidin-FITC for LNP Trafficking Assays
2026-09-17
Streptavidin-FITC converts biotinylated nanoparticles, nucleic acids, and antibodies into measurable fluorescent signals for microscopy and flow cytometry. Its strongest use in LNP research is not simply measuring uptake, but separating particle association, intracellular trafficking, and functional delivery across surface-charge and cell-state conditions.
-
5-Azacytidine Triggers ATR-Dependent DNA Damage
2026-09-17
The reference study shows that 5-azacytidine kills therapy-sensitive, therapy-resistant, and multidrug-resistant multiple myeloma cells through predominantly ATR-mediated DNA double-strand break responses and both caspase-dependent and caspase-independent apoptosis. Its synergy with doxorubicin and bortezomib provides a mechanistic preclinical rationale for combination strategies, although clinical translation requires validation beyond the cellular models examined.
-
Self-Adaptive Nanocarriers for Pancreatic Cancer
2026-09-16
The ACS Nano study presents DATCPT, a pH/reactive oxygen species-responsive camptothecin nanocarrier designed to overcome circulation, stromal, penetration, and metastatic barriers in orthotopic pancreatic cancer. Its sequential charge adaptation, ROS-triggered matrix remodeling, and drug release provide a coordinated delivery strategy that is more mechanistically integrated than conventional passive nanocarriers.
-
Adefovir: From HBV Polymerase to OAT1
2026-09-16
Adefovir and GS-0393 connect HBV polymerase inhibition with renal transporter biology. This article explains how to translate potency, exposure, formulation, and OAT1 kinetics into more interpretable hepatitis B virus research assays.
-
RRP Restores Lipid Metabolism in Liver I/R Injury
2026-09-15
A 2024 Journal of Ethnopharmacology study found that Radix Rehmanniae Praeparata extracts reduced hepatic ischemia-reperfusion injury by rebalancing cholesterol synthesis and efflux. Its mechanistic contribution is the linkage of AMPK activation to suppression of the SCAP-SREBP2 axis and enhancement of LXRα-dependent cholesterol export in mouse and lipid-loaded hepatocyte models.
-
Radiopathomics and Immunotherapy Response in Gastric Cancer
2026-09-15
A multicenter study developed an interpretable radiopathomics signature by combining baseline CT imaging with digital H&E pathology to predict response to immunotherapy-based combination therapy in gastric cancer. The signature achieved strong discrimination across training, internal validation, and external validation cohorts and also identified prognostic differences associated with immune regulation and memory B-cell infiltration.
-
Dovitinib (TKI-258): ERK-to-Apoptosis Workflows
2026-09-14
Dovitinib (TKI-258) provides a practical way to perturb multiple RTK inputs while tracking ERK, STAT, viability, and apoptosis responses in cancer models. This workflow connects a melanoma signaling discovery to disciplined assay design for multiple myeloma research, hepatocellular carcinoma treatment research, and broader RTK-driven studies.
-
Topotecan: From DNA Lesion to Assay Design
2026-09-14
Topotecan, also known as SKF104864, is more than a Topo I inhibitor: it is a schedule-dependent DNA damage probe. This guide connects its mechanism, recurrent SCLC evidence, and practical assay design for translational cancer research.
-
Docosahexaenoic Acid (DHA) Research Workflows
2026-09-13
Build oxidation-conscious DHA experiments for membrane biology, neuroprotection research, inflammation, and retinal models. This guide connects practical dosing and assay design with an arachidonic-acid immune study while clearly separating evidence for DHA from hypothesis-generating extensions.